Overview
- 49 inspections across 44 sites are on record.
- 120 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-09-25.
At a glance
Inspections
49
Sites
44
Observations
120
Career since
Oct 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Genzyme Corporation | 25 Sep 2014 | Human Drugs | On file |
| Parcell Laboratories | 14 Feb 2013 | Biologics | On file |
| New England Cryogenic Center, Inc. | 13 Feb 2013 | Biologics | On file |
| BFS Pharma, Inc. | 17 Jan 2013 | View 483 → | |
| PolyCarbon Industries, Inc. | 20 Dec 2012 | On file |
Sites inspected
Genzyme CorporationFramingham, United States1 insp.
Parcell LaboratoriesNatick, United States1 insp.
New England Cryogenic Center, Inc.Marlborough, United States1 insp.
BFS Pharma, Inc.Randolph, United States1 insp.
PolyCarbon Industries, Inc.Newburyport, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ramon E Martinez9 shared
Kent A Conforti4 shared
Megan A Haggerty4 shared
Philip Kreiter4 shared
Robert C Horan3 shared
Stacey S Degarmo2 shared
Amy C Jordan2 shared
Nichole B Murphy2 shared
Justine M Corson2 shared
Robert J Martin2 shared
Full investigator report
Get the verbatim findings behind Rory Geyer's 120 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site